GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nanobac Pharmaceuticals NNBP · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Nanobac Pharmaceuticals — daily NNBP Delayed
Market value
$24,520
Last close × shares
Volume
1k
Shares, 30 Oct 2026

About Nanobac Pharmaceuticals

Its shares trade under the ticker NNBP. It has been listed since 21 June 2001. In the fiscal year to 31 December 2007, it reported revenue of $17,621 and a net loss of $6.6m. At that date it held total assets of $7.2m and shareholders' equity of −$2.4m.

Nanobac Pharmaceuticals, Inc. owns and operates community health centers. The company is headquartered in Tampa, Florida. The company went IPO on 2001-06-21. The firm is primarily engaged in the discovery and development of products and services to improve people’s health through the detection and treatment of Calcifying Nanoparticles (CNPs), otherwise known as nanobacteria. Its research is directed toward establishing the pathogenic role of nanobacteria in soft tissue calcification, particularly in coronary artery heart disease, prostatitis and vascular disease. Nanobac’s drug discovery and development is focused on new and existing compounds that inhibit, destroy or neutralize CNPs. Nanobac manufactures and markets In Vitro Diagnostic (IVD) kits and reagents for detecting calcifying nanoparticles. IVD products (blood and tissue tests) include assays, antibodies and reagents for recognizing CNPs.

Figures and description from our data supplier, not checked against the company's own report.

More about Nanobac Pharmaceuticals →

Latest on Nanobac Pharmaceuticals

Our reporting

We have not reported on Nanobac Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Nanobac Pharmaceuticals's ticker?

Nanobac Pharmaceuticals trades as NNBP on its US listing, under ISIN US63007M1027.

What was Nanobac Pharmaceuticals's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.